CellaVision AB (publ) (LON:0MR5)
London · Delayed Price · Currency is GBP · Price in SEK 150.20
-0.60 (-0.40%)
At close: Dec 17, 2025
CellaVision AB Market Cap
CellaVision AB has a market cap or net worth of 296.1 million as of December 19, 2025. Its market cap has decreased by -19.08% in one year.
Market Cap
296.10M
Enterprise Value
285.50M
Revenue
59.09M
Ranking
n/a
PE Ratio
24.77
Stock Price
150.20
Market Cap Chart
Since May 28, 2007, CellaVision AB's market cap has increased from 27.41M to 296.10M, an increase of 980.39%. That is a compound annual growth rate of 13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 296.10M | -21.11% |
| Dec 30, 2024 | 375.34M | -4.64% |
| Dec 29, 2023 | 393.61M | -9.49% |
| Dec 30, 2022 | 434.88M | -31.55% |
| Dec 30, 2021 | 635.34M | -3.33% |
| Dec 30, 2020 | 657.25M | 5.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.44B |
| HSBC Holdings | 190.63B |
| Shell | 150.64B |
| Unilever | 106.14B |
| Rio Tinto Group | 96.74B |
| British American Tobacco p.l.c. | 93.03B |
| Rolls-Royce Holdings | 91.91B |
| GSK plc | 73.06B |